RAB5A transports β3-integrin and MT1-MMP to invadopodia, through a RAB4-dependent pathway, allowing their maturation into competent ECM-degrading structures, which promotes invasion of metastatic BC cells (Frittoli et al., 2014). This evidence concerns the gene RAB5A and breast cancer.